Letter from the Editor EditorProf. dr Peter C.M. van de Kerkhof, Radboud University Nijmegen Medical Centre, the Netherlands ConferenceSPIN 2019 21 June 2019 12:45
Treatment goals in psoriasis Presented ByProf. Ulrich Mrowietz ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 12:44
Understanding genetics to unravel psoriasis and atopic dermatitis pathogenesis Presented ByProf. Jonathan Barker, Kings College London, United Kingdom ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 20:34
Atopic dermatitis and psoriasis: on a spectrum? Presented ByProf. Emma Guttman-Yassky, Mount Sinai Medical School, USA ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 13:39
Advances in target-oriented therapy: psoriatic arthritis Presented ByProf. Wolf-Henning Boehncke, University of Geneva, Switzerland TrialECLIPSA, TICOPA ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 23:48
Favourable safety profile of long-term use of ixekizumab Presented ByProf. Kristian Reich, Georg-August-University Göttingen, Germany ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 22:50
Brodalumab onset of action is significantly faster than ustekinumab: Results from the phase 3 AMAGINE-2 and -3 studies Presented ByDr Sandra Philipp, Charité-Universitätsmedizin Berlin, Germany TrialPhase 3, AMAGINE ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 21:59
Adalimumab vs adalimumab + methotrexate in psoriasis: First-year results on effectiveness, drug survival, safety, and immunogenicity Presented ByDr Gayle van der Kraaij, Amsterdam UMC, the Netherlands ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 20:57
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients Presented ByDr Sandra Phillip, Charité-Universitätsmedizin Berlin, Germany TrialPhase 3, CADMUS Jr ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 19:59
Fumarates and vitamin A derivatives advance and latest insights in non-biologic systemic therapeutic agents in psoriasis and atopic dermatitis Presented ByProf. Peter van de Kerkhof, Radboud University Medical Center, the Netherlands ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 18:02
Certolizumab: Long-term safety and efficacy results for psoriasis-related nail disease Presented ByProf. Andrew Blauvelt, Oregon Medical Research Center, USA TrialPhase 3, CIMPASI ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 15:05
Granulomatous rosacea: exploratory histological markers Presented ByDr EunHye Hong, Hallym University Sacred Heart Hospital, Korea ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 20:10
Live imaging of cutaneous immune responses Presented ByProf. Kenji Kabashima, Kyoto University, Japan ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 19:19
Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis? Presented ByProf. Kristian Reich, Georg-August-University Göttingen, Germany TrialECLIPSE ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 18:23
ABP501 biosimilar for adalimumab: What you need to know Presented ByProf. Brian Kirby, St Vincent's Hospital, Dublin, Ireland ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 17:24
Switching infliximab biosimilars safe in treating chronic plaque psoriasis ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 16:26
Sustained and complete responses from the phase 3 AMAGINE-2 and -3 studies Presented ByProf. Lluís Puig, Hospital de la Santa Creu i Sant Pau, Spain TrialPhase 3, AMAGINE ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 15:29
Reduction in coronary artery disease in psoriasis patients treated with biologic therapies, possible implications for atopic dermatitis Presented ByDr Nehal Mehta; Prof. Emma Guttman-Yassky TrialNHANES ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 14:38
Treatment goals in psoriasis Presented ByProf. Ulrich Mrowietz ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 12:44
Small molecules, apremilast, and TYK2 Presented ByProf. Richard Langley, Dalhousie University, Canada TrialESTEEM, PALACE, LIBERATE ConferenceSPIN 2019 TypePeer-reviewed article 21 June 2019 09:45